An ROR1 small molecule inhibitor (SMI) could induce dephosphorylation of ROR1 in CLL cells as well as of canonical and non‐canonical Wnt signaling proteins with subsequent induction of apoptosis [5]. This evidence concerns the gene ROR1 and B-cell chronic lymphocytic leukemia.